NCT01311076 - TAK-329 Glucose Clamp Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2011

Primary Completion Date

December 31, 2011

Study Completion Date

January 31, 2012

Conditions

Type 1 Diabetes Mellitus

Interventions

DRUG

TAK-329

TAK-329 50 mg, tablets, orally, single dose, one day.

DRUG

TAK-329

TAK-329 200 mg, tablets, orally, single dose, one day.

DRUG

Insulin

Insulin 0.2 U/kg, subcutaneous injection, single dose, one day.

DRUG

Placebo

TAK-329 placebo-matching tablets, orally, single dose, one day.

Trial Locations (1)

Chula Vista